October 25, 2026 12:20 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Jamia shifts classes online after clash over demand for student union polls; Congress MPs face allegations | Deadly mid-air collision: Four pilots killed as two military aircraft crash in Philippines | ‘Jihad’ calls, Modi assassination remarks: Mumbai Rapido driver arrested over alleged Jaish links | Vegetarian-only kitchen at Keralam Lok Bhavan? Governor's reported order triggers political backlash | ‘Another little Epic Fury’: Trump’s chilling warning to Iran as fresh US strikes loom | Bomb threat email names Amitabh Bachchan’s Jalsa bungalow, Diljit Dosanjh’s concert venue: Reports | ‘Face-offs still continue’: ITBP chief reveals fresh India-China border tensions in Arunachal | Eiffel Tower women staff row: BAPS monk blames ‘miscommunication’, denies delegation's role | ‘Pen, not stones and guns’: RSS-linked group opens its first office in Kashmir Valley under Muslim leader | First human case of Shamonda virus reported in France; WHO confirms death of immunocompromised patient
Adar Poonawalla | Covid vaccine
Image Credit: Adar Poonawalla Twitter

Vaccine hesitancy is now the greatest threat in overcoming pandemic: Adar Poonawalla

| @indiablooms | Nov 18, 2021, at 06:04 am

New Delhi/IBNS:  Serum Institute of India chief Adar Poonawalla, whose pharma company manufactured COVID-19 vaccine Covishield, on Wednesday said the hesitancy to get inoculated is the "greatest threat" in overcoming the pandemic.

Urging all those eligible to get vaccinated as soon as possible, Poonawalla said there are "over 200 million doses" of Covishield vaccine available with states.

"The vaccine industry has worked tirelessly to provide enough stocks for the nation. Today there are over 200 million doses available with states. I urge all adults to get vaccinated as soon as possible. Vaccine hesitancy is now the greatest threat in overcoming this pandemic," he said in a tweet.

AstraZeneca and Oxford University developed  Covishield and Bharat Biotech's Covaxin are the two widely used vaccines against COVID-19 in India.

India’s COVID-19 vaccination coverage has crossed 114 crore landmark milestone on Wednesday, the Centre informed in its late night bulletin.

"More than 65 lakh (65,73,687) Vaccine Doses have been administered till 7 pm today.  The daily vaccination tally is expected to increase with the compilation of the final reports for the day by late tonight," the statement read.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.